CP-Renal: Percutaneous Cryoablation of Central Kidney Tumours With Temporary Renal Artery Occlusion

Sponsor

University Hospital, Strasbourg, France (Other)

Overall Status

Recruiting

CT.gov ID

NCT05461027

Collaborator

(none)

Enrollment

Location

Anticipated Duration (Months)

0.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Percutaneous cryoablation is an alternative to urological surgery for T1a tumours, whose oncological efficacy decreases for the most central tumours due to a cold sink effect.

Condition or Disease	Intervention/Treatment	Phase
Kidney Cancer

Study Design

Study Type:

Observational

Anticipated Enrollment :

16 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

Percutaneous Cryoablation of Central Kidney Tumours With Temporary Renal Artery Occlusion

Actual Study Start Date :

May 1, 2022

Anticipated Primary Completion Date :

Dec 31, 2023

Anticipated Study Completion Date :

Dec 31, 2023

Outcome Measures

Primary Outcome Measures

Description of the technique of percutaneous cryoablation of central renal tumours with temporary balloon obliteration of the renal artery [Files analysed retrospectively from January 01, 2018 to December 31, 2021 will be examined]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Inclusion criteria:

Adult subject (≥18 years)
Subject who has undergone cryoablation of a central kidney tumour with temporary occlusion of the renal artery by an endovascular balloon at the HUS during the period 01/01/2018 to 30/12/2021
Subject who has not expressed his/her opposition, after information, to the re-use of his/her data for the purpose of this research.